Zhi-Dong Ge
Overview
Explore the profile of Zhi-Dong Ge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
1022
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Filipp M, Ge Z, DeBerge M, Lantz C, Glinton K, Gao P, et al.
Circulation
. 2025 Mar;
PMID: 40071347
Background: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment options remain limited. The HFpEF syndrome is associated with a high comorbidity burden, including...
2.
Lantz C, Becker A, DeBerge M, Filipp M, Glinton K, Ananthakrishnan A, et al.
Immunity
. 2025 Feb;
58(2):344-361.e7.
PMID: 39938482
In response to organ injury in adults, macrophages often promote scarring, yet during early life, they are required for tissue regeneration. To elucidate the mechanisms underlying age-associated regeneration, we compared...
3.
DeBerge M, Glinton K, Lantz C, Ge Z, Sullivan D, Patil S, et al.
Nat Cardiovasc Res
. 2025 Jan;
4(1):83-101.
PMID: 39747455
Myocardial infarction (MI) mobilizes macrophages, the central protagonists of tissue repair in the infarcted heart. Although necessary for repair, macrophages also contribute to adverse remodeling and progression to heart failure....
4.
Glinton K, Thakkar A, Jones R, Inui H, Ge Z, Thorp E
J Mol Cell Cardiol
. 2024 Nov;
198():13-20.
PMID: 39592090
Advances in genetic, pharmacologic, and sequencing technology have led to new insight into the role of lymphatics in health and disease. This includes fundamental aspects of the crosstalk between immune...
5.
Piccolo E, Ge Z, Filipp M, Sullivan D, Thorp E, Sumagin R
Am J Physiol Heart Circ Physiol
. 2024 Sep;
327(5):H1230-H1243.
PMID: 39331023
Heart failure is a major cause of mortality following myocardial infarction. Neutrophils are among the first immune cells to accumulate in the infarcted region. Although beneficial functions of neutrophils in...
6.
Baumgardt S, Fang J, Fu X, Liu Y, Xia Z, Zhao M, et al.
Cardiovasc Res
. 2024 Jul;
120(12):1456-1471.
PMID: 39001869
Aims: The histone deacetylase 6 (HDAC6) inhibitor, tubastatin A (TubA), reduces myocardial ischaemia/reperfusion injury (MIRI) in type 1 diabetic rats. It remains unclear whether HDAC6 regulates MIRI in type 2...
7.
Tan C, Ge Z, Kurup S, Dyakiv Y, Liu T, Muller W, et al.
Arterioscler Thromb Vasc Biol
. 2024 Jul;
44(9):1944-1959.
PMID: 38989578
Background: Mitral valve (MV) disease including myxomatous degeneration is the most common form of valvular heart disease with an age-dependent frequency. Genetic evidence indicates that mutations of the human transcription...
8.
Saha P, Guru S, Ge Z, Simms L, Chen L, Bolli R, et al.
Stem Cell Rev Rep
. 2024 Jun;
20(7):1843-1853.
PMID: 38941039
Intravenous infusion has been used as the method of cell delivery in many preclinical studies as well as in some early clinical trials. Among its advantages are broad distribution, ability...
9.
Ren K, Hou S, Johnson S, Lomasney J, Haney C, Lee J, et al.
J Am Heart Assoc
. 2024 Apr;
13(9):e032577.
PMID: 38639350
Background: The goal was to determine the feasibility of mapping the injured-but-not-infarcted myocardium using Tc-duramycin in the postischemic heart, with spatial information for its characterization as a pathophysiologically intermediate tissue,...
10.
Guru S, Saha P, Chen L, Tulshyan A, Ge Z, Baily J, et al.
Stem Cell Rev Rep
. 2023 Jun;
19(6):2038-2051.
PMID: 37261668
Stem cell therapy provides a hope to no option heart disease patient group. Stem cells work via different mechanisms of which paracrine mechanism is reported to justify most of the...